GRI Bio, Inc. (GRI) Q1 2026 Earnings
GRI·Reported May 13, 2026·Before market open
Diluted EPS came in at $-1.61, missed the $-0.91 consensus by $0.70.
Diluted EPS
$-1.61missed by $0.70
Consensus: $-0.91
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about GRI Bio, Inc.'s Q1 2026 earnings report.
GRI Bio, Inc. (GRI) reported Q1 2026 earnings on May 13, 2026 before market open.
GRI Bio, Inc. reported diluted EPS of $-1.61 for Q1 2026.
EPS missed the consensus estimate of $-0.91 by $0.70.
You can read the 8-K earnings release (0001824293-26-000046) and the 10-Q periodic report (0001824293-26-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.